BR9809284A - Construto e processo para expressão de polinucleotìdeo em altos nìveis - Google Patents
Construto e processo para expressão de polinucleotìdeo em altos nìveisInfo
- Publication number
- BR9809284A BR9809284A BR9809284-7A BR9809284A BR9809284A BR 9809284 A BR9809284 A BR 9809284A BR 9809284 A BR9809284 A BR 9809284A BR 9809284 A BR9809284 A BR 9809284A
- Authority
- BR
- Brazil
- Prior art keywords
- construct
- level
- polynucleotide expression
- processes
- materials
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/121—Hammerhead
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/122—Hairpin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/127—DNAzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/025—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a parvovirus
Abstract
"CONSTRUTO E PROCESSO PARA EXPRESSãO DE POLINUCLEOTìDEO EM ALTOS NìVEIS". A presente invenção provê materiais e processos para expressão eficiente, específica, de proteínas nas células retinianas. Estes materiais e processos podem ser usados em terapias para doenças retinianas. Em uma concretização, as ribozimas que degradam mRNA mutante são usadas para tratar retinite pigmentosa.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4449297P | 1997-04-21 | 1997-04-21 | |
US4614697P | 1997-05-09 | 1997-05-09 | |
PCT/US1998/008003 WO1998048027A2 (en) | 1997-04-21 | 1998-04-21 | Materials and methods for treatment of retinal diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9809284A true BR9809284A (pt) | 2004-08-03 |
Family
ID=26721632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9809284-7A BR9809284A (pt) | 1997-04-21 | 1998-04-21 | Construto e processo para expressão de polinucleotìdeo em altos nìveis |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0977880A2 (pt) |
JP (1) | JP2001527399A (pt) |
AU (1) | AU7467598A (pt) |
BR (1) | BR9809284A (pt) |
CA (1) | CA2287495A1 (pt) |
WO (1) | WO1998048027A2 (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8551970B2 (en) | 1996-04-02 | 2013-10-08 | Optigen Patents Limited | Genetic suppression and replacement |
US20040234999A1 (en) * | 1996-04-02 | 2004-11-25 | Farrar Gwenyth Jane | Genetic suppression and replacement |
US6225291B1 (en) | 1997-04-21 | 2001-05-01 | University Of Florida | Rod opsin mRNA-specific ribozyme compositions and methods for the treatment of retinal diseases |
JP2002542805A (ja) | 1999-04-30 | 2002-12-17 | ユニバーシティ オブ フロリダ | アデノ随伴ウイルス送達リボザイム組成物および使用方法 |
JP2003531609A (ja) * | 2000-05-01 | 2003-10-28 | ノバルティス アクチエンゲゼルシャフト | 目に関する形質導入用ベクターおよび遺伝子治療を目的とするその用途 |
EP1381276A4 (en) | 2001-04-13 | 2005-02-02 | Univ Pennsylvania | METHOD FOR TREATMENT OR DEVELOPMENT SLUDGE DEGRADATION |
CN101484005A (zh) | 2006-05-04 | 2009-07-15 | 韦恩州立大学 | 通过向体内递送视紫红质核酸恢复视觉响应 |
EP2315833B8 (en) | 2008-05-20 | 2015-05-27 | Eos Neuroscience, Inc. | Vectors for delivery of light-sensitive proteins and methods of use |
EP2539015B1 (en) | 2010-02-26 | 2015-12-30 | Cornell University | Retina prosthesis |
GB2492719A (en) | 2010-04-05 | 2013-01-09 | Eos Neuroscience Inc | Methods and compositions for decreasing chronic pain |
WO2011140279A1 (en) | 2010-05-04 | 2011-11-10 | Wayne State University | Aav-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells |
BR112013004964A2 (pt) | 2010-08-31 | 2017-05-23 | Univ Cornell | aparelho protético para recuperar ou melhorar a visão de um indivíduo em necessidade do mesmo |
US9302103B1 (en) | 2010-09-10 | 2016-04-05 | Cornell University | Neurological prosthesis |
SG10201912961QA (en) * | 2011-05-18 | 2020-03-30 | Univ California | Compositions and Methods for Treating Retinal Diseases |
CA2883091C (en) | 2011-08-25 | 2020-02-25 | Cornell University | Retinal encoder for machine vision |
WO2013063601A1 (en) * | 2011-10-28 | 2013-05-02 | University Of Florida Research Foundation, Inc. | Chimeric promoter for cone photoreceptor targeted gene therapy |
US10947281B2 (en) | 2012-03-05 | 2021-03-16 | Wayne State University | Identification of channelrhodopsin-2 (ChR2) mutations and methods of use |
JP7016522B2 (ja) | 2015-04-20 | 2022-02-07 | コーネル ユニヴァーシティー | 次元データ低減を有するマシンビジョン |
AU2020212026A1 (en) * | 2019-01-23 | 2021-07-22 | University Of Florida Research Foundation, Incorporated | Highly efficient transduction and lateral spread in the retina by a novel AAV virus enhanced by rational design |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9519299D0 (en) * | 1995-09-21 | 1995-11-22 | Farrar Gwyneth J | Genetic strategy |
-
1998
- 1998-04-21 EP EP98922042A patent/EP0977880A2/en not_active Withdrawn
- 1998-04-21 WO PCT/US1998/008003 patent/WO1998048027A2/en not_active Application Discontinuation
- 1998-04-21 BR BR9809284-7A patent/BR9809284A/pt not_active IP Right Cessation
- 1998-04-21 CA CA002287495A patent/CA2287495A1/en not_active Abandoned
- 1998-04-21 AU AU74675/98A patent/AU7467598A/en not_active Abandoned
- 1998-04-21 JP JP54626898A patent/JP2001527399A/ja not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
CA2287495A1 (en) | 1998-10-29 |
AU7467598A (en) | 1998-11-13 |
WO1998048027A3 (en) | 1999-03-25 |
WO1998048027A9 (en) | 1999-04-29 |
WO1998048027A2 (en) | 1998-10-29 |
EP0977880A2 (en) | 2000-02-09 |
JP2001527399A (ja) | 2001-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9809284A (pt) | Construto e processo para expressão de polinucleotìdeo em altos nìveis | |
BR9808606A (pt) | Materiais e métodos para tratamento de doenças com ribozimas | |
Banik et al. | Role of Calpain in Spinal Cord Injury: Effects of Calpain and Free Radical Inhibitors a | |
BR9808153A (pt) | Processo para melhorar a fotossìntese | |
ATE326239T1 (de) | Verfahren zur behandlung von ig-e assozierten krankheiten und zusammensetzungen zur verwendung in diesen verfahren | |
IL187254A (en) | ANTISENSE NUCLEOTIDES, COMPOSITIONS COMPRISING THEREOF AND THEIR USE IN MODULATING ACTIVATION OF NF-kB | |
DE69434218D1 (de) | Photodynamische behandlung von synovium | |
BR9815419A (pt) | genes desaturase e uso dos mesmos | |
DE69731540D1 (de) | Behandlung von diarrhoe | |
EP0710288A4 (en) | ADENOVIRAL VECTORS FOR TREATMENT OF HEMOPHILIA | |
TW200728465A (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
BR0213786A (pt) | Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células | |
ATE413179T1 (de) | Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden | |
GB9422175D0 (en) | Indentification of the p21 waf1-pcna interaction site and therapeutic applications thereof | |
ATE293700T1 (de) | Adenovirus mit glutathion peroxydate gene | |
WO1998037185A3 (en) | Vectors for controlled gene expression | |
ATE459355T1 (de) | Verfahren zur behandlung von erkrankungen mit mangel an thiolhaltiger verbindung | |
WO1999041364A3 (en) | Compositions and methods for wound healing | |
EP1100507A4 (en) | ANTIOXIDANT COMPOSITION AND USE THEREOF FOR THE TREATMENT OF CONDITIONS | |
EA199700241A1 (ru) | Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран | |
BR9814284A (pt) | Composições e métodos para regulação de fagocitose e expressão de icam-1 | |
WO2000009658A3 (en) | Gene regulating circadian clock function and photoperiodism | |
ES2170144T3 (es) | Variantes que no se empalman de gp350/220. | |
DE69534753D1 (de) | Nierenpolycystose-gen | |
AU4312093A (en) | Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1891 DE 03/04/2007. |